Kanda T, Yamawaki M, Ariga T, Yu R K
Department of Biochemistry and Molecular Biophysics, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0614, USA.
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7897-901. doi: 10.1073/pnas.92.17.7897.
Treatment of cultured bovine brain microvascular endothelial cells (BMECs) with interleukin 1 beta (IL-1 beta), an inflammatory cytokine, was shown to induce the accumulation of sulfoglucuronosyl paragloboside (SGPG), a glycolipid bearing the HNK-1 epitope. This resulted in the attachment of a greater number of human lymphocytes to the treated than to the untreated BMEC monolayers. Attachment of human lymphocytes to the IL-1 beta-activated BMEC cells could be blocked either by incubation of the human lymphocytes with an anti-L-selectin antibody or by application of an anti-SGPG antibody to the BMECs. These results suggest that SGPG may act as an important ligand for L-selectin for the regulation of the attachment of activated lymphocytes and their subsequent invasion into the nervous system parenchyma in inflammatory disorders of the central and peripheral nervous systems.
用炎性细胞因子白细胞介素1β(IL-1β)处理培养的牛脑微血管内皮细胞(BMECs),结果显示可诱导硫酸葡萄糖醛酸神经节苷脂(SGPG)的积累,SGPG是一种带有HNK-1表位的糖脂。这导致与未处理的BMEC单层相比,更多的人淋巴细胞附着于经处理的细胞。人淋巴细胞与IL-1β激活的BMEC细胞的附着可通过用抗L-选择素抗体孵育人淋巴细胞或通过向BMECs应用抗SGPG抗体来阻断。这些结果表明,SGPG可能作为L-选择素的重要配体,在中枢和外周神经系统炎性疾病中调节活化淋巴细胞的附着及其随后侵入神经实质。